Scholars@Duke

A new era in secondary prevention after acute coronary syndrome.

Publication ,  Journal Article
Roe, MT; Ohman, EM
Published in: N Engl J Med
January 5, 2012
Published version (DOI) Link to item

Duke Scholars

Matthew Todd Roe
Author Matthew Todd Roe Medicine, Cardiology

Published In

N Engl J Med

DOI

10.1056/NEJMe1112770

EISSN

1533-4406

Publication Date

January 5, 2012

Volume

366

Issue

1

Start / End Page

85 / 87

Location

United States

Related Subject Headings

  • Thiophenes
  • Rivaroxaban
  • Morpholines
  • Male
  • Humans
  • General & Internal Medicine
  • Female
  • Factor Xa Inhibitors
  • Anticoagulants
  • Acute Coronary Syndrome
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Roe, M. T., & Ohman, E. M. (2012). A new era in secondary prevention after acute coronary syndrome. N Engl J Med, 366(1), 85–87. https://doi.org/10.1056/NEJMe1112770
Roe, Matthew T., and E Magnus Ohman. “A new era in secondary prevention after acute coronary syndrome.” N Engl J Med 366, no. 1 (January 5, 2012): 85–87. https://doi.org/10.1056/NEJMe1112770.
Roe MT, Ohman EM. A new era in secondary prevention after acute coronary syndrome. N Engl J Med. 2012 Jan 5;366(1):85–7.
Roe, Matthew T., and E. Magnus Ohman. “A new era in secondary prevention after acute coronary syndrome.” N Engl J Med, vol. 366, no. 1, Jan. 2012, pp. 85–87. Pubmed, doi:10.1056/NEJMe1112770.
Roe MT, Ohman EM. A new era in secondary prevention after acute coronary syndrome. N Engl J Med. 2012 Jan 5;366(1):85–87.

Published In

N Engl J Med

DOI

10.1056/NEJMe1112770

EISSN

1533-4406

Publication Date

January 5, 2012

Volume

366

Issue

1

Start / End Page

85 / 87

Location

United States

Related Subject Headings

  • Thiophenes
  • Rivaroxaban
  • Morpholines
  • Male
  • Humans
  • General & Internal Medicine
  • Female
  • Factor Xa Inhibitors
  • Anticoagulants
  • Acute Coronary Syndrome